2NolphK,GokalR,Mujais S. ISPD ultrafdtration managementin peritonealAdHoc dialysis[J].Committee PeruDial,2000.3-5.
3Rippe B,Venturoli D,Smonseni O. lFluid and electrolyte transport across the peritonealmembrane duringCAPD according to the three-poremodel[J].PeritDial Int,2004.10-27.
4Krdeiet,Lindholm B,Rippe B. Pathophysiology of peritonealmem-brane failure[J].PeritDial Int,2007.22-42.
5Williams JD,CraigKJ,TopleyN. Morphologic changes in the peritonealmembrane ofpatientswith renal disease[J].Soc Nephro1,2008.470-479.
7Liu YH,liu FY,ZhangH. EffectofHighGlucose on theCellProliferation,Damage and Cytokine in Human PeritonealMesothelial Cells[J].Medical Journal Zhergnan Univercity,2008.575-579.
8HaH. ChaMK,ChoiHN,Effects of peritoneal dialysissolutions on the secretion of growth factors and extracel-lularmatrix proteins by human peritonealmesothelial cells[J].PeritonealDialysis Int,2002.171-177.
9YokoY,MasanobuM,KatsushigeA. TNP-470,an angiogenesis inhibitor,suppresses the progression ofperi toneal fibrosis in mouse experimentalmodel[J].Kidney International,2004.1677-1685.
10Comb S,Miyata T,Moulin P. Vascular proliferation and enhanced expression ofendothelialnitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis[J].Soc Nephro1,2000.717-728.
9Bender FH, Bemardini J, Piraino B. Prevention of infectious complications in peritoneal dialysis : best demonstrated practices [ J ]. Kidney Int Suool.2006(103) :S44-S54.
10Raaijmakers R,Schroder C, Monnens L. Fungal peritonitis in children on peritoneal dialysis[J]. Pediatr Nephrol,2007,22(17) :288-293.
